Laura M Dember, Jesse Y Hsu, Leah Bernardo, Kerri L Cavanaugh, David M Charytan, Susan T Crowley, Daniel Cukor, Ardith Z Doorenbos, David A Edwards, Denise Esserman, Michael J Fischer, Manisha Jhamb, Steven Joffe, Kirsten L Johansen, Sahir Kalim, Francis J Keefe, Paul L Kimmel, Erin E Krebs, Natalie Kuzla, Rajnish Mehrotra, Puneet Mishra, Bethany Pellegrino, Jennifer L Steel, Mark L Unruh, David M White, Jonathan G Yabes, William C Becker
The HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis (HOPE Trial) is a multicenter randomized trial addressing chronic pain among patients receiving maintenance hemodialysis for end-stage kidney disease. The trial uses a sequential, multiple assignment design with a randomized component for all participants (Phase 1) and a non-randomized component for a subset of participants (Phase 2). During Phase 1, participants are randomized to Pain Coping Skills Training (PCST), an intervention designed to increase self-efficacy for managing pain, or Usual Care...
December 10, 2023: Contemporary Clinical Trials